EUVIMEDEUVIMED entdecken
VergleichsstudieOpen Access · CC BY-NC 4.0

Understanding Australian Pharmacists’ Perceptions on the Utilisation of Oral 5-HT3 Antagonists as Pharmacist-Only Anti-Emetics in Comparison to Oral D2 Antagonists

Aiden Hendry, Jack Janetzki, Wern Chern Chai iD

Journal of Pharmacy Practice · 2024

DOI: 10.1177/08971900241236379 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift Journal of Pharmacy Practice, 2024. Verfasst von Aiden Hendry und 2 weiteren Autor:innen. Beteiligte Einrichtung: Clinical and Health Sciences, University of South Australia, Adelaide, AU-SA, Australia. Hauptthemen laut MEDLINE: Pharmacists, Antiemetics, Serotonin 5-HT3 Receptor Antagonists. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 9 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

To investigate the perception of community pharmacists on the down-scheduling of 5-HT3 antagonists to pharmacist-only-medicine for treatment of acute nausea and/or vomiting in Australia.

Methods

A nationwide anonymous survey targeting Australian community pharmacists was conducted from April to May 2023. Responses were collected and analysed quantitively or qualitatively, where appropriate. Key findings: Participants reported that 5-HT3 antagonists were effective at treating nausea and/or vomiting and would likely recommend their use. Training is required to manage supply due to concerns related to their side effects.

Conclusion

Participants supported down-scheduling of 5-HT3 antagonists for the treatment of nausea and/or vomiting in Australia. A pilot study on the provision of 5-HT3 antagonists by pharmacists is recommended as is the development of guidelines for pharmacist-only supply before down-scheduling is considered.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PharmacistsAntiemeticsSerotonin 5-HT3 Receptor AntagonistsHumansAustraliaMaleFemaleAdultMiddle AgedAdministration, OralVomitingDopamine D2 Receptor AntagonistsSurveys and QuestionnairesCommunity Pharmacy ServicesAttitude of Health PersonnelNauseaProfessional Role

Stichwörter der Autor:innen

5-HT3 antagonistsD2 antagonistscommunity pharmacistsnausea and/or vomitingschedule 3 medicines

Substanzen

AntiemeticsSerotonin 5-HT3 Receptor AntagonistsDopamine D2 Receptor Antagonists

Autor:innen und Institutionen

  • Clinical and Health Sciences, University of South Australia, Adelaide, AU-SA, Australia.
  • Quality Use of Medicines and Pharmacy Research Centre, Clinical and Health Sciences, University of South Australia, Adelaide, AU-SA, Australia.
  • Health and Biomedical Innovation, Clinical and Health Sciences, University of South Australia, Adelaide, AU-SA, Australia.

ORCID-Profile: Wern Chern Chai

Zitieren

APA

Hendry, A., Janetzki, J., & Chai, W. C. (2024). Understanding Australian Pharmacists’ Perceptions on the Utilisation of Oral 5-HT3 Antagonists as Pharmacist-Only Anti-Emetics in Comparison to Oral D2 Antagonists. Journal of Pharmacy Practice. https://doi.org/10.1177/08971900241236379

Vancouver

Hendry A, Janetzki J, Chai WC. Understanding Australian Pharmacists’ Perceptions on the Utilisation of Oral 5-HT3 Antagonists as Pharmacist-Only Anti-Emetics in Comparison to Oral D2 Antagonists. Journal of Pharmacy Practice. 2024. doi:10.1177/08971900241236379

BibTeX
@article{Hendry2024,
  author = {Hendry, Aiden and Janetzki, Jack and Chai, Wern Chern},
  title = {Understanding Australian Pharmacists’ Perceptions on the Utilisation of Oral 5-HT3 Antagonists as Pharmacist-Only Anti-Emetics in Comparison to Oral D2 Antagonists},
  journal = {Journal of Pharmacy Practice},
  year = {2024},
  doi = {10.1177/08971900241236379}
}
Kostenlos starten →